Skip to content

The random control clinical trial of the clinical effects between three kinds of cervical artificial disc and anterior cervical discectomy and fusion.

The random control clinical trial of the clinical effects between three kinds of cervical artificial disc and anterior cervical discectomy and fusion.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002172
Enrollment
Unknown
Registered
2012-05-14
Start date
2012-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical degenerative disease

Interventions

Bryan:bryan artificial disc replacement
Discovery:Discovery artificial disc replacement
Mobic-C:Mobic-C artificial disc replacement
ACDF?:anterior cervical discectomy and fusion

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The indications of cervical artificial disc arthroplasty in this series were symptomatic cervical disc disease including cervical disc herniation or cervical spondylosis at 1 or 2 levels between C3–C7 confirmed by physical examination and imaging study (magnetic resonance imaging (MRI) and computed tomography myelography (CTM)).

Exclusion criteria

Exclusion criteria: Contraindications included severe facet arthritis, lack of motion or instability at the operation level, spinal canal narrowing, fracture, infection, tumor, OPLL, allergic, or osteoporosis.

Design outcomes

Primary

MeasureTime frame
JOA score;SF-36 score;neck disability index;FSU angulation;FSU range of motion;cervical angulation;cervical range of motion;adjacent segment degeneration;Facet joint degenetation;Heterotopic ossification;

Countries

China

Contacts

Public ContactWei Tian
tianweijst@vip.163.com+86 13801280790

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026